Flavonoid-drug interactions: Effects of flavonoids on ABC transporters

被引：215

作者：

Morris, ME ^{[1
]}

Zhang, SZ ^{[1
]}

机构：

[1] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Amherst, NY 14260 USA

来源：

LIFE SCIENCES | 2006年 / 78卷 / 18期

关键词：

ABC proteins; p-glycoprotein; MRP; BCRP; breast cancer resistance protein; flavonoids; herbal dietary supplements;

D O I：

10.1016/j.lfs.2005.12.003

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Flavonoids are present in fruits, vegetables and beverages derived from plants (tea, red wine), and in many dietary supplements or herbal remedies including Ginkgo Biloba, Soy Isoflavones, and Milk Thistle. Flavonoids have been described as health-promoting, disease-preventing dietary supplements, and a high intake of flavonoids has been associated with a reduced risk of cancer, cardiovascular diseases, osteoporosis and other age-related degenerative diseases. Due to an increased public interest in alternative medicine and disease prevention, the use of herbal preparations containing high doses of flavonoids for health maintenance has become very popular, raising the potential for interactions with conventional drug therapies. This review will summarize the current literature regarding the interactions of flavonoids with ATP-binding cassette (ABC) efflux transporters, mainly P-glycoprotein, MRP1, MRP2 and BCRP and discuss the potential consequences for flavonoid-drug transport interactions. (c) 2005 Elsevier Inc. All rights reserved.

引用

页码：2116 / 2130

页数：15

共 189 条

[1] Phase II study of flavopiridol in patients with advanced colorectal cancer [J].

Aklilu, M ;

Kindler, HL ;

Donehower, RC ;

Mani, S ;

Vokes, EE .

ANNALS OF ONCOLOGY, 2003, 14 (08) :1270-1273

[2]

Allen JD, 2002, MOL CANCER THER, V1, P427

[3]

Allen JD, 1999, CANCER RES, V59, P4237

[4]

Allikmets R, 1998, CANCER RES, V58, P5337

[5] PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].

AMBUDKAR, SV ;

LELONG, IH ;

ZHANG, JP ;

CARDARELLI, CO ;

GOTTESMAN, MM ;

PASTAN, I .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476

[6] GRAPEFRUIT JUICE FELODIPINE INTERACTION - MECHANISM, PREDICTABILITY, AND EFFECT OF NARINGIN [J].

BAILEY, DG ;

ARNOLD, JMO ;

MUNOZ, C ;

SPENCE, JD .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (06) :637-642

[7] A family of drug transporters: The multidrug resistance-associated proteins [J].

Borst, P ;

Evers, R ;

Kool, M ;

Wijnholds, J .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302

[8] The multidrug resistance protein family [J].

Borst, P ;

Evers, R ;

Kool, M ;

Wijnholds, J .

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (02) :347-357

[9] Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance [J].

Boumendjel, A ;

Di Pietro, A ;

Dumontet, C ;

Barron, D .

MEDICINAL RESEARCH REVIEWS, 2002, 22 (05) :512-529

[10] B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance [J].

Boumendjel, A ;

Bois, F ;

Beney, C ;

Mariotte, AM ;

Conseil, G ;

Di Pietro, A .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (01) :75-77

← 1 2 3 4 5 6 7 8 9 10 →